AAAAAA
Results:
1-12
|
Results: 12
Authors:
GURNEY HP
ACKLAND S
GEBSKI V
FARRELL G
Citation: Hp. Gurney et al., FACTORS AFFECTING EPIRUBICIN PHARMACOKINETICS AND TOXICITY - EVIDENCEAGAINST USING BODY-SURFACE AREA FOR DOSE CALCULATION, Journal of clinical oncology, 16(7), 1998, pp. 2299-2304
Authors:
COATES A
GEBSKI V
Citation: A. Coates et V. Gebski, QUALITY-OF-LIFE STUDIES OF THE AUSTRALIAN-NEW-ZEALAND-BREAST-CANCER-TRIALS-GROUP - APPROACHES TO MISSING DATA, Statistics in medicine, 17(5-7), 1998, pp. 533-540
Authors:
HUSSAIN R
CHRISTIE DRH
GEBSKI V
BARTON MB
GRUENEWALD SM
Citation: R. Hussain et al., THE ROLE OF THE GALLIUM SCAN IN PRIMARY EXTRANODAL LYMPHOMA, The Journal of nuclear medicine, 39(1), 1998, pp. 95-98
Authors:
HARRIS AW
BASTEN A
GEBSKI V
NOONAN D
FINNIE J
BATH ML
BANGAY MJ
REPACHOLI MH
Citation: Aw. Harris et al., A TEST OF LYMPHOMA INDUCTION BY LONG-TERM EXPOSURE OF E-MU-PIM1 TRANSGENIC MICE TO 50 HZ MAGNETIC-FIELDS, Radiation research, 149(3), 1998, pp. 300-307
Authors:
BYRNE MJ
GEBSKI V
FORBES J
TATTERSALL MHN
SIMES RJ
COATES AS
DEWAR J
LUNN M
FLOWER C
GILL PG
STEWART J
Citation: Mj. Byrne et al., MEDROXYPROGESTERONE ACETATE ADDITION OR SUBSTITUTION FOR TAMOXIFEN INADVANCED TAMOXIFEN-RESISTANT BREAST-CANCER - A PHASE-III RANDOMIZED TRIAL, Journal of clinical oncology, 15(9), 1997, pp. 3141-3148
Authors:
BARTON MB
MORGAN G
SMEE R
TIVER KW
HAMILTON C
GEBSKI V
Citation: Mb. Barton et al., DOES WAITING TIME AFFECT THE OUTCOME OF LARYNX CANCER TREATED BY RADIOTHERAPY, Radiotherapy and oncology, 44(2), 1997, pp. 137-141
Authors:
REPACHOLI MH
BASTEN A
GEBSKI V
NOONAN D
FINNIE J
HARRIS AW
Citation: Mh. Repacholi et al., LYMPHOMAS IN E-MU-PIM1 TRANSGENIC MICE EXPOSED TO PULSED 900 MHZ ELECTROMAGNETIC-FIELDS, Radiation research, 147(5), 1997, pp. 631-640
Authors:
COATES A
GEBSKI V
Citation: A. Coates et V. Gebski, ON THE RECEIVING END .4. WHICH DIMENSIONS OF QUALITY-OF-LIFE SCORES CARRY PROGNOSTIC INFORMATION, Cancer treatment reviews, 22, 1996, pp. 63-67
Authors:
MOLLAND JG
BARRACLOUGH BH
GEBSKI V
MILLIKEN J
BILOUS M
Citation: Jg. Molland et al., PROGNOSTIC-SIGNIFICANCE OF C-ERBB-2 ONCOGENE IN AXILLARY NODE-NEGATIVE BREAST-CANCER, Australian and New Zealand journal of surgery, 66(2), 1996, pp. 64-70
Authors:
STENNING HM
STENNING DBB
RAJASEKARIAH GR
STADLERPRELEC M
GEBSKI V
Citation: Hm. Stenning et al., THE LONSTENN - A NEW CERVICAL SAMPLING DEVICE, International journal of gynecological cancer, 5(6), 1995, pp. 426-431
Authors:
CHRISTIE DRH
BULL CA
GEBSKI V
LANGLANDS AO
Citation: Drh. Christie et al., CONCURRENT 5-FLUOROURACIL, MITOMYCIN-C AND IRRADIATION IN LOCALLY ADVANCED CERVIX CANCER, Radiotherapy and oncology, 37(3), 1995, pp. 181-189
Authors:
GILL PG
GEBSKI V
SNYDER R
BURNS I
LEVI J
BYRNE M
COATES A
Citation: Pg. Gill et al., RANDOMIZED COMPARISON OF THE EFFECTS OF TAMOXIFEN, MEGESTROL-ACETATE,OR TAMOXIFEN PLUS MEGESTROL-ACETATE ON TREATMENT RESPONSE AND SURVIVAL IN PATIENTS WITH METASTATIC BREAST-CANCER, Annals of oncology, 4(9), 1993, pp. 741-744
Risultati:
1-12
|